Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Brain Imaging01:14

Brain Imaging

Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delusional parasitosis with shared psychotic features secondary to vitamin B12 deficiency and mild cognitive impairment: a case report.

BMC psychiatry·2026
Same author

Clinical dilemma of mood stabilizer augmentation in treatment-resistant schizophrenia with residual phase: A case report of valproate-associated hypoglycemia and cytopenia, and subsequent lithium response.

PCN reports : psychiatry and clinical neurosciences·2026
Same author

Ethanolamine as a potential biomarker and therapeutic target for depressive disorder.

Molecular psychiatry·2026
Same author

Evaluating and Determining the Effects of Psychotropic Drugs on Motor Vehicle Driving Performance: Key Considerations of the Japanese Guideline and Criteria for Clinical Implementation of Evidence.

Neuropsychopharmacology reports·2026
Same author

A Data-Driven Psychiatric Disorder Subtype Defined by Significant Enlarged Ventricles and Cognitive Impairment: A Replication Study.

Neuropsychopharmacology reports·2026
Same author

Antidepressants Target the ST3GAL5-GM3 Lipid Pathway to Suppress Microglial Inflammation.

International journal of molecular sciences·2025
Same journal

Navigating Emergency Management: Perspective From Gen-Z Using Modified Disaster Preparedness Evaluation Tools.

Journal of UOEH·2026
Same journal

Exploring the Impact of Sleep Quality on Periodontal Health among Night Shift Factory Workers in Ahmedabad City.

Journal of UOEH·2026
Same journal

Evaluating Ergonomic Risks in Manual Lychee Harvesting Using PATH and Hierarchical Task Analysis: An Observational Cross-Sectional Study.

Journal of UOEH·2026
Same journal

Isolated Fallopian Tube Torsion in a 16-Year-Old Adolescent: A Diagnostic Challenge Mimicking a Functional Ovarian Cyst.

Journal of UOEH·2026
Same journal

Effect of Light-Intensity Physical Activity in An Older-Adult Patient With Minimal Change Nephrotic Syndrome and Acute Kidney Injury: A Case Report.

Journal of UOEH·2026
Same journal

Association between Family Supportive Supervisor Behaviors and Work Functioning Impairment.

Journal of UOEH·2026
See all related articles

Related Experiment Video

Updated: Jun 5, 2026

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

Major Depression and Brain-Derived Neurotrophic Factor.

Reiji Yoshimura1,2

  • 1Emeritus Professor of University of Occupational and Environmental Health, Japan.

Journal of UOEH
|June 3, 2026
PubMed
Summary
This summary is machine-generated.

Brain-derived neurotrophic factor (BDNF) shows promise as a biomarker for depression, with its levels and genetic variations linked to severity and treatment. Future research aims to integrate BDNF analysis for personalized depression care.

Keywords:
biomarkerbrain-derived neurotrophic factormajor depressionpolymorphismprecision medicine

More Related Videos

Real-time Imaging of Axonal Transport of Quantum Dot-labeled BDNF in Primary Neurons
10:53

Real-time Imaging of Axonal Transport of Quantum Dot-labeled BDNF in Primary Neurons

Published on: September 15, 2014

An Improved Protocol to Purify and Directly Mono-Biotinylate Recombinant BDNF in a Tube for Cellular Trafficking Studies in Neurons
13:46

An Improved Protocol to Purify and Directly Mono-Biotinylate Recombinant BDNF in a Tube for Cellular Trafficking Studies in Neurons

Published on: July 11, 2020

Related Experiment Videos

Last Updated: Jun 5, 2026

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

Real-time Imaging of Axonal Transport of Quantum Dot-labeled BDNF in Primary Neurons
10:53

Real-time Imaging of Axonal Transport of Quantum Dot-labeled BDNF in Primary Neurons

Published on: September 15, 2014

An Improved Protocol to Purify and Directly Mono-Biotinylate Recombinant BDNF in a Tube for Cellular Trafficking Studies in Neurons
13:46

An Improved Protocol to Purify and Directly Mono-Biotinylate Recombinant BDNF in a Tube for Cellular Trafficking Studies in Neurons

Published on: July 11, 2020

Area of Science:

  • Neuroscience
  • Psychiatry
  • Genetics

Background:

  • Depression exhibits significant biological and psychosocial heterogeneity, complicating biomarker identification.
  • Brain-derived neurotrophic factor (BDNF) is implicated in depression, with blood levels, genetic variations, and cerebrospinal fluid concentrations correlating with disease status and treatment outcomes.

Purpose of the Study:

  • To explore the role of BDNF and its related pathways in depression.
  • To investigate the potential of BDNF as a diagnostic and prognostic biomarker for depression.
  • To examine the influence of BDNF genetic polymorphisms and epigenetic modifications on treatment response.

Main Methods:

  • Analysis of blood levels, genetic polymorphisms, and cerebrospinal fluid concentrations of BDNF.
  • Assessment of the mBDNF/proBDNF ratio, p75NTR, and tropomyosin receptor kinase B.
  • Evaluation of the Val66Met polymorphism and epigenetic changes in the BDNF gene.

Main Results:

  • BDNF levels, genetic variations, and cerebrospinal fluid concentrations correlate with depression severity and treatment response.
  • Changes in the mBDNF/proBDNF ratio, p75NTR, and tropomyosin receptor kinase B are associated with neuroplasticity.
  • The Val66Met polymorphism and epigenetic modifications of the BDNF gene may affect treatment responsiveness.

Conclusions:

  • BDNF holds potential as a key biomarker in understanding and treating depression.
  • Personalized medicine for depression may be advanced through standardized BDNF measurement, AI analysis, and multifactorial integration.